基本信息
views: 1
Career Trajectory
Bio
Selected Grants
A Randomized Phase II Study of Nivolumab and Temozolomide vs Temozolomide alone in newly diagnosed elderly patients with Glioblastoma (NUTMEG) awarded by University of Sydney 2020 - 2022
Awards that do not permit publicity, particularly prior to 2012, are not displayed.
A Randomized Phase II Study of Nivolumab and Temozolomide vs Temozolomide alone in newly diagnosed elderly patients with Glioblastoma (NUTMEG) awarded by University of Sydney 2020 - 2022
Awards that do not permit publicity, particularly prior to 2012, are not displayed.
Research Interests
Papers共 331 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ECLINICALMEDICINE (2024): 102457-102457
CNS oncologyno. 1 (2024): CNS105-CNS105
Nicholas Simafranca, Bryant Willoughby, Erin O’Neil, Sophie Farr,Brian J. Reich,Naomi Giertych,Margaret C. Johnson,Madeleine A. Pascolini-Campbell
Environmental and Ecological Statisticspp.1-22, (2024)
Kirit Singh,Matthew W Foster, Marlene J Violette,Kelly M Hotchkiss, Chelsea O Railton, Emily E Blandford, Kathryn E Blethen, Elizabeth L Thomas,David M Ashley,Annick Desjardins,Henry S Friedman,Margaret O Johnson,
medrxiv(2024)
SEMINARS IN NEUROLOGYno. 01 (2024): 47-52
Erdal Tasci,Yajas Shah,Sarisha Jagasia,Ying Zhuge, Jason Shephard,Margaret O. Johnson,Olivier Elemento, Thomas Joyce, Shreya Chappidi,Theresa Cooley Zgela,Mary Sproull,Megan Mackey,
Frontiers in Systems Biology (2023)
NEURO-ONCOLOGYno. Supplement_5 (2023): v260-v260
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn